Dexpramipexole [dexpramipexol]
topical
- Terms
-
(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazol-diamin
(R)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol
(R)-pramipexol
KNS 760704
KNS-760704
KNS760704
pramipexol, (R)-izomer
R-(+)-pramipexol
SND 919CL2x
SND-919CL2x
SND919CL2x
-
(6R)-4,5,6,7-Tetrahydro-N6-Propyl-2,6-Benzothiazole-Diamine
(R)-2-Amino-6-Propylamino-4,5,6,7-Tetrahydrobenzothiazole
(R)-Pramipexole
KNS 760704
KNS-760704
KNS760704
Pramipexol, (R)-isomer
R-(+)-Pramipexole
SND 919CL2x
SND-919CL2x
SND919CL2x
Persistent link
https://www.medvik.cz/link/D000097662
Definition
The (R)-(+) enantiomer of PRAMIPEXOLE. Dexpramipexole has lower affinity for DOPAMINE RECEPTORS than pramipexole.
- DUI
- D000097662 MeSH Browser
- CUI
- M000607801
- History note
- 2024; use PRAMIPEXOLE 2019-2023
- Public note
- 2024; see PRAMIPEXOLE 2019-2023
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.708.089.111
Dexpramipexole
D03.383.129.708.089.416
Ethoxzolamide
D03.633.100.185.111
Dexpramipexole
D03.633.100.185.416
Ethoxzolamide